about
Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitroThe natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1Effect of brown adipose tissue/cells on the growth of mouse hepatocellular carcinoma andCCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducingA Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic CancerAzithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivoHonokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation
P50
Q36745823-02953524-DAAE-46D8-85C5-78D57547BB1DQ37374435-8E387732-532A-4025-8F13-B739C3438D85Q37623392-1D2E1C42-BED4-48A4-8727-BD861FBD1DBDQ38609949-9C3755D8-2F71-425A-A34A-04CB350F36D4Q38857537-6E1AE5EE-34FA-4089-B10A-DC094354DF6AQ38966179-0F893FB1-13D9-4B6F-B2D8-E5EF2A4E9E9FQ40016123-42A191CD-5C85-4D9A-8287-7D80BCC6387DQ46507423-131BFB8F-38DC-4033-A740-A97D65CAF0D0Q51123259-6D98A8D5-2551-4A70-B020-CBE72CE472D5Q61813554-F8F71084-8C44-4880-AA43-BD425B96F1D8Q64234141-A15475C7-C580-4DE0-8313-E7385FB99CD8Q80761103-86053DC9-27F8-4627-9328-F70A9CB9C9B9Q88662538-92E8CAC5-D9C1-4F9C-877E-D899269D4233Q89407845-F3447F5F-E1AC-4DD6-A1F1-DFF61F369299Q93000522-16990585-0273-4FC3-BE05-1EDA47E0F8FC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shu-zhen Chen
@ast
Shu-zhen Chen
@en
Shu-zhen Chen
@es
Shu-zhen Chen
@nl
type
label
Shu-zhen Chen
@ast
Shu-zhen Chen
@en
Shu-zhen Chen
@es
Shu-zhen Chen
@nl
prefLabel
Shu-zhen Chen
@ast
Shu-zhen Chen
@en
Shu-zhen Chen
@es
Shu-zhen Chen
@nl
P106
P1153
7410252149
P31
P496
0000-0003-4881-0558